Iain FarranceBiologist at CBER, FDASpeaker
Agenda Sessions
CMC considerations for Cell Therapy Product INDs
, 5:00pmView SessionCMC considerations for Cell Therapy Product INDs
, 5:00pmView Session
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
CMC considerations for Cell Therapy Product INDs
CMC considerations for Cell Therapy Product INDs